Hsp90 inhibitors for therapeutic treatment

Details Hsp90 inhibitors for therapeutic treatment Hsp90 inhibitors for therapeutic treatment

A - Human Necessities

61

K

A61K 31/519 (2006.01) A61K 31/00 (2006.01) A61P 17/06 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2743722

The use of a Hsp90 inhibitor for the treatment of cancer of the bladder, the colon, the liver, the lung, the breast, the vagina, the ovaries, the pancreas, the kidney, the stomach, the gastrointestinal tract, the prostate, the head and neck, the peritoneal cavity, the thyroid, the bone, the brain, the central nervous system and/or the blood and/or for the treatment of myelodysplastic syndrome, systemic mastocytosis, von Hippel-Lindau syndrome, multicentric Castleman disease and/or psioriasis.

L'invention concerne l'utilisation d'un inhibiteur de Hsp90 dans le traitement du cancer de la vessie, du colon, du foie, du poumon, du sein, du vagin, des ovaires, du pancréas, du rein, de l'estomac, du tractus gastro-intestinal, de la prostate, de la tête et du cou, de la cavité péritonéale, de la thyroïde, des os, du cerveau, du système nerveux central et/ou de la leucémie et/ou dans le traitement du syndrome myélodysplasique, de la mastocytose systémique, du syndrome de Von Hippel-Lindau, de la maladie de Castleman multicentrique et/ou du psoriasis.

Affiliated with

Also associated with

Rating

Hsp90 inhibitors for therapeutic treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hsp90 inhibitors for therapeutic treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hsp90 inhibitors for therapeutic treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1417020